Results 61 to 70 of about 19,665 (228)
Relevance of application of the Yamaguchi criteria for patients with suspected juvenile idiopathic arthritis in the absence of arthritis symptoms [PDF]
, 2014 Aim of the study: Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation beside arthritis. Many children may have delayed onset of arthritis.
Azza El Hamshary +4 more
core +1 more source
Cytokine status and hemostasis disorders in children with juvenile idiopathic arthritis
Acta Biomedica ScientificaJuvenile idiopathic arthritis is a chronic inflammatory joint disease in children under 16 years of age associated with pathological immune response to various antigens. Probable factors are infectious and immunogenetic.
M. V. Gomellya +3 more
doaj +1 more source
Leflunomide in systemic onset juvenile idiopathic arthritis
Indian Pediatrics, 2012 Methotrexate, the mainstay of treatment in Juvenile idiopathic arthritis, might not be effective in a few patients of polyarticular and systemic onset juvenile idiopathic arthritis. Use of biologicals like TNF-a blockers, the next line of preferred drugs is constrained by the high cost. We successfully used leflunomide in four patients.
Afsana, Jahan +2 more
openaire +2 more sources
New frontiers in the treatment of systemic juvenile idiopathic arthritis [PDF]
F1000Research, 2017 Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines, such interleukins 1 and 6, has changed the treatment ...
Susan Canny, Elizabeth Mellins
openaire +2 more sources
Arthritis &Rheumatology, EarlyView.Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher +12 more
wiley +1 more source
Journal of Baghdad College of Dentistry, 2016 Background: Juvenile idiopathic arthritis (JIA) is a chronic disease of childhood. Increased prevalence of periodontal disease and dental caries in juvenile idiopathic arthritis is due to difficulties in executing good oral hygiene.
Zainab Shallan, Nadia Aftan Al-Rawi
doaj +1 more source
Pediatric Rheumatology Online Journal, 2022 Background The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed consensus treatment plans (CTPs) to compare treatment initiation strategies for systemic juvenile idiopathic arthritis (sJIA).
Timothy Beukelman +11 more
doaj +1 more source
Association of Childhood Acute Leukemia With Autoimmune Diseases
International Journal of Cancer, EarlyView.A possible link exists between various pediatric autoimmune diseases (AIDs) and increased risk of childhood leukemia. Although immune dysregulation is a key feature of these conditions, the connection between them remains unclear. In this study, using cancer registry data in Finland, the authors examined associations between AIDs and childhood acute ...
Ida Pellikka +4 more
wiley +1 more source
Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis [PDF]
The Journal of Clinical Pharmacology, 2014 Systemic juvenile idiopathic arthritis (sJIA) is a disease characterized by arthritis in children
Julie Autmizguine +3 more
openaire +2 more sources